AU2002238673A1 - Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof - Google Patents

Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof

Info

Publication number
AU2002238673A1
AU2002238673A1 AU2002238673A AU2002238673A AU2002238673A1 AU 2002238673 A1 AU2002238673 A1 AU 2002238673A1 AU 2002238673 A AU2002238673 A AU 2002238673A AU 2002238673 A AU2002238673 A AU 2002238673A AU 2002238673 A1 AU2002238673 A1 AU 2002238673A1
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
composition containing
specific antibody
therapeutic uses
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002238673A
Inventor
Pierre Marie Martin
L'houcine Ouafik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Assistance Publique Hopitaux de Marseille APHM
Original Assignee
Sanofi Synthelabo SA
Assistance Publique Hopitaux de Paris APHP
Assistance Publique Hopitaux de Marseille APHM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA, Assistance Publique Hopitaux de Paris APHP, Assistance Publique Hopitaux de Marseille APHM filed Critical Sanofi Synthelabo SA
Publication of AU2002238673A1 publication Critical patent/AU2002238673A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
AU2002238673A 2001-02-20 2002-02-20 Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof Abandoned AU2002238673A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0102291A FR2821080B1 (en) 2001-02-20 2001-02-20 SPECIFIC ANTIBODIES TO HUMAN ADRENOMEDULLINE, PHARMACEUTICAL COMPOSITION CONTAINING SAME, ITS THERAPEUTIC APPLICATIONS
FR01/02291 2001-02-20
PCT/FR2002/000638 WO2002066492A2 (en) 2001-02-20 2002-02-20 Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof

Publications (1)

Publication Number Publication Date
AU2002238673A1 true AU2002238673A1 (en) 2002-09-04

Family

ID=8860234

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002238673A Abandoned AU2002238673A1 (en) 2001-02-20 2002-02-20 Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof

Country Status (3)

Country Link
AU (1) AU2002238673A1 (en)
FR (1) FR2821080B1 (en)
WO (1) WO2002066492A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004028352A2 (en) * 2002-09-30 2004-04-08 Bayer Pharmaceuticals Corporation Methods for prediction and prognosis of cancer, and monitoring cancer therapy
JO3382B1 (en) 2008-12-23 2019-03-13 Amgen Inc Human cgrp receptor binding antibodies
FR2964103B1 (en) * 2010-08-30 2018-11-23 Universite D'aix-Marseille ANTIBODIES BINDING TO ADRENOMEDULLINE AND RECEPTORS OF ADRENOMEDULLINE AND THEIR USES AS A MEDICINAL PRODUCT
EP2589963A1 (en) * 2011-11-04 2013-05-08 Université de Provence (Aix-Marseille 1) Diagnostic and treatment of an androgen-independent prostate cancer
AR101875A1 (en) 2014-09-15 2017-01-18 Amgen Inc ANTIGENS, BI-SPECIFIC UNION PROTEIN OF THE ANTI-CGRP RECEIVER / PAC1 RECEIVER AND USES OF THE SAME
JOP20200116A1 (en) 2015-04-24 2017-06-16 Amgen Inc Methods for treating or preventing migraine headache
EP3774881A1 (en) 2018-04-02 2021-02-17 Amgen Inc. Erenumab compositions and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774769B2 (en) * 1993-04-26 1998-07-09 賢治 寒川 Adrenomedullin
EP0845036B1 (en) * 1995-08-18 1999-06-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology

Also Published As

Publication number Publication date
FR2821080A1 (en) 2002-08-23
WO2002066492A3 (en) 2003-02-27
WO2002066492A2 (en) 2002-08-29
FR2821080B1 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
HUP0402566A3 (en) C-5 modified indazolylamino pyrrolotriazines, their use and pharmaceutical compositions containing them
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2002258063A1 (en) Medicament applicator
AU2003222347A1 (en) Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
AU2002257582A1 (en) Pharmaceutical formulation
AU2002302147A1 (en) Pharmaceutical composition
AU2002258221A1 (en) Medicinal composition
HUP0402028A3 (en) Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
AU2002360117A1 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU2002238673A1 (en) Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
AU2002244865A1 (en) Pharmaceutical composition of ibuprofen
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
AU2002354460A1 (en) Medicinal composition
AUPR529701A0 (en) Pharmaceutical composition
AU2002365148A1 (en) Human ras interacting protein
AU2002364684A1 (en) Amphiphilic compounds for pharmaceutical or cosmetic use
AU2002361450A1 (en) Novel pharmaceutical
AU2002313036A1 (en) Novel 5-thio-B-D-xylopyranoside Derivatives, Preparation Method Thereof, Pharmaceutical Compositions Containing Same and the Therapeutic Use Thereof
AU2002100921A4 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase